Apyx medical corporation receives fda 510(k) clearance for the use of renuvion® to improve appearance of lax (loose) skin

Clearwater, fla.--(business wire)--apyx medical corporation (nasdaq:apyx) (the “company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as renuvion®, today announced it has received 510(k) clearance from the u.s. food and drug administration (“fda”) for the use of the renuvion apr handpiece for certain skin contraction procedures. specifically, the renuvion apr handpieces are now indicated for use in subcutaneous dermatological and aesthetic pr
APYX Ratings Summary
APYX Quant Ranking